NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-132108

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedCrohn's Disease
Date of first enrollment01/5/2013
Target sample size60
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : KRP-203 Dosage And administration of the intervention : Oral, Once daily Control intervention name : Placebo Dosage And administration of the control intervention : Oral, Once daily

Outcome(s)

Primary OutcomeCDAI The improvement of CDAI.
Secondary OutcomeInflammation markers,etc. CRP, etc.

Key inclusion & exclusion criteria

Age minimum15
Age maximum64
GenderBOTH
Include criteria-Patients who were diagnosed with Crohn's disease according to diagnostic criteria, etc.
Exclude criteria-Patients with a colostomy or ileostomy. -Patients with a short gut syndrome or imflammatory bowel disease except Crohn's disease, etc.

Related Information

Contact

public contact
Name Kyorin Pharmaceutical Co.,Ltd. Clinical Development Center
Address develop3@mb.kyorin-pharm.co.jp
Telephone
E-mail
Affiliation
scientific contact
Name Kyorin Pharmaceutical Co.,Ltd. Clinical Development Center
Address develop3@mb.kyorin-pharm.co.jp
Telephone
E-mail
Affiliation